Argentine Registry of Acute Heart Failure (ARGEN-IC). Evaluation of a Partial Cohort at 30 Days

Adrián Lescano, Guillermina Soracio, Julieta Soricetti, Diego Arakaki, Lorena Coronel, Leonardo Cáceres, Hernán Cohen Arazi, Analía Benavidez, Alfredo Hirschson Prado, Alberto Fernández


Introduction: Acute Heart Failure is currently an epidemiological problem, with a close correlation with the increase in thepopulation age and the greater survival of patients with cardiovascular diseases.Objectives: Evaluate the clinical profile, the diagnostic and therapeutic strategies and the complications during hospitalizationand the 12-month follow up of the ARGEN IC Registry.Materials and Methods: It’s a prospective, multicenter, national Registry which included 50 health centers (August 2018-March 2019) and included patients with a confirmed diagnosis of acute heart failure with a 12-month follow-up.Results: A total of 909 patients were included, corresponding to 18 provinces and 73 active researchers. The mean age was 72.2(SD 14) years, 60.5% of the patients were males. Baseline characteristics include a prevalence of diabetes of 33%, previousAMI 17%, and Atrial Fibrillation 31% and a predominant private security medical coverage (38%) Among the trigger factorsof decompensation, 28.5% were associated with unknown causes, 15.7% infectious causes, and 13.5% with food transgression.The ischemic-necrotic etiology (26%), the presentation as mixed congestion (48%) and the impaired ejection fraction (EF)group stand out. 77.6% of the patients were admitted to the critical care unit, with a median overall hospital stay of 8 daysand overall mortality of 7.9%. The pharmacological treatment at discharge, including the group with reduced EF: Beta Blockers(BB) 78.7%, ACEI, ARA II or ARNI 70.9% and anti aldosteronic 56.3% and the referral to cardiovascular rehabilitationin 17%. The 30-day follow-up showed a rehopitalization rate of 16.7%, mortality of 5.5% and combined events of 18%. Only47% accessed the medical consultation.Conclusions: The ARGEN-IC Registry represents a heterogeneous population, with high middle ages and comorbidities. Thediagnostic and therapeutic strategies are underutilized during hospitalization and in the first 30 days, with poor access tothe health system. The overall combined rate of in-hospital events and at 30 days remains high.


Gheorghiade M, Vaduganathan M, Fonarow G, Bonow R. Rehospitalizationfor Heart Failure. J Am Coll Cardiol 2013;61:391-40.

Mc MurrayJJ, Adamopoulos S, Anker SD, Aurichio A, Bohm M,

Dickstein K, et al. ESC Guidelines for the Diagnosis and Treatment

of Acute and Chronic Heart Failure. Eur Heart J 2012;33:1787-84

Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006;27:65-75.

Greene S, Fonarow G, Vaduganathan M, Khan S, Butler J and

Gheorghiade M. The vulnerable phase after hospitalization for heart

failure. Nat Rev Cardiol 2015;12:220-9.

Thierer J, Iglesias D, Ferrante D, Marino J, Diez M, Rolong B,

et al. Registro Nacional de Internación por Insuficiencia Cardíaca.

Factores responsables, evolución hospitalaria y predictores de mortalidad.Rev Argent Cardiol 2002;70:261-73.

Rizzo M, Thierer J, Francesia A, Bettati MI, Pérez Terns P, Casas

M. Registro Nacional de Internación por Insuficiencia Cardíaca 2002-2003. Rev Argent Cardiol 2004;72:333-40.

Fairman E, Thierer J, Rodríguez L, Blanco P, Guetta J, FernándezS y col. Registro Nacional de Internación por Insuficiencia Cardiaca2007. Rev Argent Cardiol 2009;77:33-9.

Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo

MR, Abraham WT, et al. Characteristics and outcomes of patients

hospitalized for heart failure in the United States: Rationale, design,

and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry ( ADHERE). Am Heart J 2005;149:209-16.

Gheorghiade M, Filippatos G. Reassessing treatment of acute failuresyndromes: The ADHERE Registry. Eur Heart J 2005; Volume

, suppl_B 13–19.

Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade

M, Warnica JW, et al. Use and impact of inotropes and vasodilator

therapy in hospitalized patients with severe heart failure. Am Heart

J 2007;153:98-104.

Hasselblad V, Gattis Stough W, Shah M, Lokhnygina Y, O’Connor CM, Califf RM, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007;9:1064-9.

Maggioni AP, Anker SD, Dahlstrom U, Filippatos G, Ponikowski

P, Zanad F, et al. Are hospitalized or ambulatory patients with heart

failure treated in accordance with European Society of Cardiology

guidelines? Eur J Heart Fail 2013;15:1173–84.

Nieminen M, Brutsaert D, Dickstein K, Drexler H, Follath F,

Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey

on hospitalized acute heart failure patients: description of population.Eur Heart J 2006;27:2725-36.

Ponikowski P.,Voors A, Anker S, Bueno H, Cleland J, Coats A, et al.Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Rev Esp Cardiol 2016;69:1167-85.

Full Text


  • There are currently no refbacks.

Licencia Creative Commons
The documents published in this journal are under the licencia Creative Commons Atribución-NoComercial-Compartir-Igual 2.5 Argentina.

Revista argentina de cardiología. ISSN en línea 1850-3748. Argentine journal of cardiology (English ed. Online ISSN 2314-2286) Sociedad Argentina de Cardiología. Azcuénaga 980 (C1115AAD),Ciudad Autónoma de Buenos Aires, República Argentina. Tel. (54 11) 4961-6027/8/9 Fax: 4961-6020